1y return+52.6%S&P 500 +20.9%
3y return+57.2%S&P 500 +68.5%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since September 30, 2022: $178 against $209 in the S&P 500.2
Armistice Capital, LLCS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| MDGLMadrigal Pharmaceuticals Inc | $154.6M | 4.3% | +8.9% |
| SUPNSupernus Pharmaceuticals | $123.1M | 3.4% | +39.6% |
| CYTKCytokinetics Inc | $102.3M | 2.8% | +57.1% |
| INCYIncyte Corp | $102.0M | 2.8% | +37.0% |
| NBIXNeurocrine Biosciences Inc | $90.3M | 2.5% | −26.0% |
| TVTXTravere Therapeutics Inc | $89.3M | 2.5% | −67.9% |
| AGIOAgios Pharmaceuticals Inc | $89.1M | 2.5% | −11.6% |
| PTCTPtc Therapeutics Inc | $87.4M | 2.4% | −48.4% |
| UNHUnitedhealth Group Inc | $76.1M | 2.1% | +23.6% |
| FRPTFreshpet Inc | $74.5M | 2.1% | +15.3% |
| DYNDyne Therapeutics Inc | $68.6M | 1.9% | −2.8% |
| AMZNAmazon Com Inc | $67.8M | 1.9% | +8.6% |
| IMVTImmunovant Inc | $66.9M | 1.9% | −51.3% |
| RIGLRigel Pharmaceuticals Inc | $65.4M | 1.8% | +30.6% |
| TMOThermo Fisher Scientific Inc | $61.4M | 1.7% | +33.9% |
| IRWDIronwood Pharmaceuticals Inc | $58.7M | 1.6% | −7.3% |
| HRMYHarmony Biosciences Hldgs In | $56.9M | 1.6% | −3.7% |
| REGNRegeneron Pharmaceuticals | $56.0M | 1.5% | +148.6% |
| NKTRNektar Therapeutics | $50.5M | 1.4% | +25.3% |
| MLYSMineralys Therapeutics Inc | $46.8M | 1.3% | +47.6% |
| SNYSanofi Sa | $45.4M | 1.3% | +254.7% |
| IMCRImmunocore Hldgs PLC | $45.3M | 1.3% | +20.2% |
| GOOGLAlphabet Inc | $45.2M | 1.3% | +6.7% |
| SLDBSolid Biosciences Inc | $42.7M | 1.2% | +33.7% |
| MDBMongodb Inc | $42.0M | 1.2% | +16.7% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| RIGLRigel Pharmaceuticals Inc | June 30, 2024 | +375.9% | $65.4M |
| AXGNAxogen Inc | September 30, 2024 | +229.5% | $35.8M |
| NKTRNektar Therapeutics | June 30, 2025 | +170.2% | $50.5M |
| GOOGLAlphabet Inc | September 30, 2021 | +167.3% | $45.2M |
| UBERUber Technologies Inc | June 30, 2020 | +132.2% | $35.9M |
| TVTXTravere Therapeutics Inc | March 31, 2021 | +127.5% | $89.3M |
| AMZNAmazon Com Inc | June 30, 2022 | +124.4% | $67.8M |
| SLDBSolid Biosciences Inc | June 30, 2025 | +105.1% | $42.7M |
| MLYSMineralys Therapeutics Inc | June 30, 2025 | +99.4% | $46.8M |
| DYNDyne Therapeutics Inc | June 30, 2023 | +97.4% | $68.6M |
Sold off last quarter
- Avanos Med IncCUSIP 05350V106 was $28.0M
- MDLNMedline Inc was $25.1M
- Kalvista Pharmaceuticals IncCUSIP 483497103 was $24.9M
- ENREnergizer Hldgs Inc was $19.7M
- METAMeta Platforms Inc was $18.6M
- Esperion Therapeutics Inc NeCUSIP 29664W105 was $10.8M
- IQVIqvia Hldgs Inc was $10.4M
- SGMOQSangamo Therapeutics Inc was $10.0M
- GEHCGe Healthcare Technologies I was $8.4M
- TENXTenax Therapeutics Inc was $7.7M
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +22.3% | +14.8% |
| March 31, 2026 | −8.0% | −4.6% |
| December 31, 2025 | +12.2% | +2.4% |
| September 30, 2025 | +20.8% | +7.8% |
| June 30, 2025 | −0.3% | +10.5% |
| March 31, 2025 | −8.3% | −4.6% |
| December 31, 2024 | −0.6% | +2.1% |
| September 30, 2024 | +6.9% | +5.4% |
| June 30, 2024 | −5.6% | +4.0% |
| March 31, 2024 | +8.0% | +10.0% |
| December 31, 2023 | +14.3% | +11.2% |
| September 30, 2023 | −9.0% | −3.6% |
| June 30, 2023 | +2.2% | +8.3% |
| March 31, 2023 | +5.2% | +7.0% |
| December 31, 2022 | +5.3% | +7.1% |
| June 30, 2022 | −11.5% | −16.5% |
| March 31, 2022 | −7.3% | −4.9% |
| December 31, 2021 | −0.2% | +10.7% |
| September 30, 2021 | −4.8% | +0.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Armistice Capital, LLC Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1601086&type=13F-HR&dateb=&owner=include&count=40CIK 1601086
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1601086/000131586326000589/Filed August 14, 2026 · accession 0001315863-26-000589